spacer
home > pmps > winter 2002 > the financial and operational benefits of e-learning in regulatory compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Financial and Operational Benefits of e-Learning in Regulatory Compliance

We believe that e-learning will increasingly be employed by pharmaceutical organisations to achieve and maintain compliance training as mandated by the regulatory authorities. e-Learning not only enhances compliance initiatives but also delivers the benefits of improved operational efficiency and higher profitability. Given the global nature of today's pharmaceutical operations, as well as an increased regulatory burden, e-learning has found a niche in the pharmaceutical manufacturing process, and ties in well with new FDA technology initiatives.

It has been well documented that e-learning cuts down the learning curve and delivers significant cost savings associated with traditional instructor led training (ILT). Furthermore, its interactive nature improves employee (student) material retention rates, and offers companies with customised solutions to their training needs. Since e-learning and computer-based training (CBT) integrates and complements traditional classroom-based training programmes, companies could achieve higher employee productivity by adopting a blended approach to learning.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Chakri Lokapriya, Managing Consultant - Compliance Solutions, and Tony Kypreos, Chief Commercial Officer, at Maersk Data UK
Chakri Lokapriya is Managing Consultant - Compliance Solutions at Maersk Data UK, a company which provides tailored audits and pilots in the areas of validation process, electronic records and signatures and computer validation. Prior to this, he was an Equity Analyst covering health care companies at JP Morgan and UBS Warburg. Chakri is a Director of Prinvex.

Tony Kypreos is Chief Commercial Officer at Maersk Data UK. Prior to this, he was European Vice-President of Strategic Services at Omnicom Group, and for nine years he held senior marketing and sales roles for Nestlй and Diageo.


spacer
Chakri Lokapriya
spacer
spacer
spacer
Tony Kypreos
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug deposition results compared to classic nasal sprays with RetroNose.
More info >>

White Papers

Trial Timelines

Thomson Reuters

Save resources with accurate trial length projections. How analytics based on curated content can deliver insight for clinical strategies.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement